COM:PROVENTIONBIO
Sanofi
- Stock
Last Close
24.98
26/04 20:00
Market Cap
2.38B
Beta: -
Volume Today
9.12M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 615.50K - | |||||||
average payables | 229.87K - | 513.87K 123.55% | 1.17M 127.97% | 4.67M 298.76% | 5.56M 18.96% | 5.15M 7.26% | ||
average receivables | 679.50K - | |||||||
book value per share | 0.59 - | 2.66 346.98% | -1.94 172.99% | -3.39 74.53% | -4.63 36.68% | 1.63 135.23% | ||
capex per share | -0.02 - | -0.02 28.09% | -0.01 30.14% | |||||
capex to depreciation | -33.67 - | -2.48 92.62% | -0.65 73.93% | |||||
capex to operating cash flow | 0.01 - | 0.01 30.78% | 0.01 4.64% | |||||
capex to revenue | -0.69 - | -0.06 91.05% | ||||||
cash per share | 0.64 - | 2.61 304.80% | 2.10 19.68% | 2.32 10.84% | 1.51 35.10% | 2.21 46.50% | ||
days of inventory on hand | 877.57 - | |||||||
days payables outstanding | 4.82K - | |||||||
days sales outstanding | 38.47 - | |||||||
debt to assets | 2.32 - | 0.10 95.62% | 0.03 70.04% | 0.04 46.84% | 2.38 5,234.94% | 0.18 92.30% | 0.49 164.60% | |
debt to equity | -1.76 - | 0.11 106.42% | 0.03 72.24% | -0.05 254.87% | -1.72 3,448.42% | -0.09 95.06% | 0.94 1,207.70% | |
dividend yield | ||||||||
earnings yield | -0.06 - | -0.67 1,089.48% | -0.07 89.57% | -0.11 59.61% | -0.32 190.87% | -0.14 55.44% | ||
enterprise value | 141.14M - | -18.82M 113.33% | 567.97M 3,118.13% | 787.04M 38.57% | 277.03M 64.80% | 769.69M 177.84% | ||
enterprise value over ebitda | -15.45 - | 0.71 104.57% | -12.80 1,913.72% | -7.90 38.32% | -2.40 69.64% | -6.17 157.53% | ||
ev to operating cash flow | -28.91 - | 0.83 102.87% | -15.75 1,994.82% | -10.31 34.53% | -2.90 71.83% | -10.21 251.44% | ||
ev to sales | 198.59 - | 59.69 69.94% | ||||||
free cash flow per share | -0.14 - | -1.01 600.28% | -0.89 12.28% | -1.48 66.81% | -1.53 3.42% | -1.02 33.21% | ||
free cash flow yield | -0.03 - | -0.57 1,803.02% | -0.06 89.58% | -0.09 46.72% | -0.27 211.73% | -0.10 64.49% | ||
graham net net | 0.58 - | 2.53 337.48% | 2.00 20.76% | -3.51 275.62% | 1.11 131.67% | 0.69 37.91% | ||
graham number | 1.90 - | 8.40 342.32% | 6.72 19.96% | 11.97 77.96% | 13.74 14.85% | 7.47 45.66% | ||
income quality | 0.53 - | 0.86 59.99% | 0.83 2.56% | 0.77 7.06% | 0.83 7.65% | 0.66 20.34% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0.25 Infinity% | |
interest coverage | 161.83 - | 791.63 389.18% | -123.59 115.61% | |||||
interest debt per share | 0.00 - | 0.01 272.83% | 0.33 4,644.79% | |||||
inventory turnover | 0.42 - | |||||||
invested capital | -0.00 - | -0.00 49.81% | 0.20 9,814.01% | |||||
market cap | 162.97M - | 39.72M 75.63% | 607.13M 1,428.50% | 888.62M 46.36% | 354.63M 60.09% | 789.82M 122.72% | ||
net current asset value | -164.71K - | 20.15M 12,334.75% | 59.66M 196.05% | 82.16M 37.71% | -179.61M 318.62% | 76.21M 142.43% | 59.64M 21.74% | |
net debt to ebitda | 2.39 - | 2.20 8.17% | 0.88 59.79% | 1.02 15.45% | 0.67 34.11% | 0.16 75.96% | ||
net income per share | -0.27 - | -1.18 337.71% | -1.04 12.23% | -1.88 81.47% | -1.81 3.50% | -1.52 16.19% | ||
operating cash flow per share | -0.14 - | -1.01 600.28% | -0.89 12.28% | -1.46 64.41% | -1.51 3.88% | -1.01 33.24% | ||
payables turnover | 0.08 - | |||||||
receivables turnover | 9.49 - | |||||||
research and ddevelopement to revenue | 49.91 - | 5.88 88.22% | ||||||
return on tangible assets | -0.41 - | -0.43 5.68% | -0.49 14.03% | -0.77 56.32% | -0.84 10.00% | -0.64 24.09% | ||
revenue per share | 0.02 - | 0.17 680.60% | ||||||
roe | -0.45 - | -0.44 2.07% | 0.53 220.26% | 0.55 3.97% | 0.39 29.40% | -0.93 337.89% | ||
roic | 0.42 - | 0.47 12.65% | -7.34 1,647.62% | 1.19 116.15% | 4.71 297.61% | -0.81 117.12% | ||
sales general and administrative to revenue | 33.94 - | 4.97 85.35% | ||||||
shareholders equity per share | 0.59 - | 2.66 346.98% | -1.94 172.99% | -3.39 74.53% | -4.63 36.68% | 1.63 135.23% | ||
stock based compensation to revenue | 8.49 - | 1.48 82.61% | ||||||
tangible asset value | -164.71K - | 20.15M 12,334.75% | 59.66M 196.05% | 82.16M 37.71% | -177.64M 316.23% | 110.73M 162.34% | 62.29M 43.75% | |
tangible book value per share | 0.59 - | 2.66 346.98% | 2.02 24.16% | -3.39 267.96% | 1.75 151.82% | 0.83 52.50% | ||
working capital | -164.71K - | 21.15M 12,940.68% | 59.66M 182.08% | 82.16M 37.71% | 109.82M 33.68% | 78.31M 28.70% | 84.26M 7.60% |
All numbers in (except ratios and percentages)